SAN FRANCISCO--(BUSINESS WIRE)--Urigen Pharmaceuticals, Inc. (OTCBB:URGP), focused on the development of treatments for urologic disorders and pain, announces a presentation at its offices on October 30, 2009 at 2PM PST. The slides presented will be posted to its website at www.urigen.com after the close of trading that day.